Furthermore, FGF1 administration significantly blocked diabetes-induced decrease of Bcl-2 expression and increase of Bax expression, subsequently upregulated Cleaved-Caspase3 expression (Fig. 4c-e, p < 0.05). This evidence concerns the gene FGF1 and diabetes mellitus.